Literature DB >> 30595189

Therapeutic Epigenetic Reprogramming of Trained Immunity in Myeloid Cells.

R M Rodriguez1, B Suarez-Alvarez2, C Lopez-Larrea3.   

Abstract

Infiltrating and tissue-resident myeloid cells are essential regulators of innate and adaptive immunity. During inflammation, and in response to microbial products, these cells can adapt to microenvironmental conditions and acquire specialized functions, including phagocytosis and the production of proinflammatory cytokines. Such myeloid plasticity is driven, in part, by epigenetic dynamics that can sustain stable phenotypes after activation, and which may lead to maladaptive cell polarization states associated with inflammation and autoimmunity. Here, we review recent reports describing epigenetic mechanisms linked to such polarization states and innate immune memory (tolerance and training) in monocyte and macrophage lineages. We discuss how these mechanisms might be targeted to develop putative immunomodulatory tools that might be used to treat a variety of immune-mediated diseases.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30595189     DOI: 10.1016/j.it.2018.11.006

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  18 in total

1.  Pleiotropic neuroprotective effects of taxifolin in cerebral amyloid angiopathy.

Authors:  Takayuki Inoue; Satoshi Saito; Masashi Tanaka; Hajime Yamakage; Toru Kusakabe; Akira Shimatsu; Masafumi Ihara; Noriko Satoh-Asahara
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-29       Impact factor: 11.205

2.  Macrophage Responses to Environmental Stimuli During Homeostasis and Disease.

Authors:  Adil Rasheed; Katey J Rayner
Journal:  Endocr Rev       Date:  2021-07-16       Impact factor: 19.871

Review 3.  Pharmacological plasticity-How do you hit a moving target?

Authors:  Michael J Parnham; Gerd Geisslinger
Journal:  Pharmacol Res Perspect       Date:  2019-11-21

Review 4.  The emerging role of epigenetic therapeutics in immuno-oncology.

Authors:  Michael J Topper; Michelle Vaz; Kristen A Marrone; Julie R Brahmer; Stephen B Baylin
Journal:  Nat Rev Clin Oncol       Date:  2019-09-23       Impact factor: 66.675

Review 5.  Maternal immune activation and neuroinflammation in human neurodevelopmental disorders.

Authors:  Velda X Han; Shrujna Patel; Hannah F Jones; Russell C Dale
Journal:  Nat Rev Neurol       Date:  2021-08-02       Impact factor: 42.937

6.  miR-9-5p regulates immunometabolic and epigenetic pathways in β-glucan-trained immunity via IDH3α.

Authors:  Haibo Su; Zhongping Liang; ShuFeng Weng; Chaonan Sun; Jiaxin Huang; TianRan Zhang; Xialian Wang; Shanshan Wu; Zhi Zhang; Yiqi Zhang; Qing Gong; Ying Xu
Journal:  JCI Insight       Date:  2021-05-10

Review 7.  Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects.

Authors:  An-Na Chen; Yan Luo; Yu-Han Yang; Jian-Tao Fu; Xiu-Mei Geng; Jun-Ping Shi; Jin Yang
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

Review 8.  Epigenetic regulation of macrophages: from homeostasis maintenance to host defense.

Authors:  Siyuan Chen; Jing Yang; Yuquan Wei; Xiawei Wei
Journal:  Cell Mol Immunol       Date:  2019-10-29       Impact factor: 11.530

9.  Memory-Like Inflammatory Responses of Microglia to Rising Doses of LPS: Key Role of PI3Kγ.

Authors:  Trim Lajqi; Guang-Ping Lang; Fabienne Haas; David L Williams; Hannes Hudalla; Michael Bauer; Marco Groth; Reinhard Wetzker; Reinhard Bauer
Journal:  Front Immunol       Date:  2019-11-08       Impact factor: 7.561

Review 10.  Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation.

Authors:  Tiansheng Li; Chao Mao; Xiang Wang; Ying Shi; Yongguang Tao
Journal:  J Exp Clin Cancer Res       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.